Detalhe da pesquisa
1.
Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study.
Vaccine
; 42(16): 3536-3546, 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38705804